You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-ADAMTS9 antibody - Spacer between TS1 and TS2 (ab39186)

    CodeSizePriceAbpointsAvailability
        
     
    • -
    •   
    •   
    •   
    •  
    •   
    •   
    Updating...

    Overview

    Product name

    Anti-ADAMTS9 antibody - Spacer between TS1 and TS2
    See all ADAMTS9 products (6) ...

    Description

    Rabbit polyclonal to ADAMTS9 - Spacer between TS1 and TS2

    Tested applications

    WBmore details

    Cross reactivity

    Reacts with

    Human

    Predicted to work with

    Mouse

    Immunogen

    The antibody is made to a synthetic peptide based on the spacer region of human ADAMTS-9, between the first and second thrombospondin domains Note: the amino acid sequence is proprietary(Peptide available as ab41246.)

    Properties

    Form

    Liquid

    Storage instructions

    Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

    Storage buffer

    Preservative: 0.05% Sodium Azide
    Constituents: 50% Glycerol

    Concentration

    Concentration information loading...

    Purity

    Immunogen affinity purified

    Clonality

    Polyclonal

    Isotype

    IgG

    Applications

    Show applications key

    Our Abpromise guarantee covers the use of ab39186 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application notes

    WB: 1/1000 - 1/5000. Predicted molecular weight: 216.5, 182.65 and 120.65 kDa Several sequences have been found for human ADAMTS-9, a 1935 amino acid sequence with predicted mass of 216.5 kDa and a pI of 7.464, a 1629 amino acid sequence with predicted mass of 182.65 and pI of 7.36, and a 1072 amino acid sequence with predicted mass of 120.65 kDa and pI of 7.618. Higher concentrations of antibody may be needed for samples from more distantly related species. EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

    Target

    Relevance

    ADAMTS proteases are secreted enzymes containing a prometalloprotease domain of the reprolysin type. The ADAMTS proteases function in processing of procollagens and von Willebrand factor as well as catabolism of aggrecan, versican and brevican. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. ADAMTS9 is closest in homology to ADAMTS20, sharing 54% overall identity, and like ADAMTS20 ADAMTS9 gas a GON like domain at the carboxyterminal end. The GON domain at the carboxyterminal end is similar to the GON1 protein in C. elegans, mutations of which lead to defective gonadal development. ADAMTS9 is expressed in ovary and testis, but little is known about the role of ADAMTS9 in reproductive organs. ADAMTS9 is also expressed in the heart, placenta, lung, skeletal tissue, and pancreas, so the protein must have wider functions than just gonadal development. ADAMTS9, like ADAMTS20, has a total of 15 thrombospondin like domains. The first TS domain begins shortly after the catalytic and disintegrin domains. TS domains 2 to 6 follow a spacer domain, followed by linker domain 1, then TS domains 7 & 8, linker domain 2, and then TS domains 9 to 15. In other ADAMTS proteins the TS motifs are thought to bind to the ECM. The ADAMTS proteins contain at least one prohormone convertase cleavage site, although it appears that one site is used preferentially, and cleavage of the propeptide domain at this site generates active enzymes. For ADAMTS9, this site is the RRTKR sequence, and the mature ADAMTS9 has an aminoterminal sequence of FLSYPR. The catalytic site of ADAMTS9 is most like ADAMTS1, 14 and 15, with an HExxHVFNMxH sequence, perhaps giving these enzymes some shared specificity.

    Cellular localization

    Secreted protein; extracellular space; extracellular matrix.

    Alternative names

    • A disintegrin and metalloproteinase with thrombospondin motifs 9 antibody
    • ADAM TS 9 antibody
    • ADAM TS9 antibody
    • A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 9 antibody
    • A disintegrin like and metalloprotease with thrombospondin type 1 motif 9 antibody
    • ADAM metallopeptidase with thrombospondin type 1 motif 9 antibody
    • ADAMTS 9 antibody
    • Cellular disintegrin related protein antibody
    • Cellular disintegrin related protein antibody
    • Disintegrin and metalloproteinase domain 9 antibody
    • FLJ42955 antibody
    • KIAA0021 antibody
    • KIAA1312 antibody
    • MCMP antibody
    • MDC9 antibody
    • MDC9 antibody
    • Meltrin gamma antibody
    • Metalloprotease disintegrin cysteine rich protein 9 antibody
    • Mltng antibody
    • Myeloma cell metalloproteinase antibody
    • Myeloma cell metalloproteinase antibody
    see all

    References for Anti-ADAMTS9 antibody - Spacer between TS1 and TS2 (ab39186)

    ab39186 has not yet been referenced specifically in any publications.

    Publishing research using ab39186? Please let us know so that we can cite the reference in this datasheet

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"